Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stehman-Breen

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Virological Methods|August 23, 2001
Investigating hepatitis C virus heterogeneity in a high prevalence setting using heteroduplex tracking analysisD G Sullivan, S S Kim, J J Wilson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 23, 1999
Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsiesC K Abrass, A K Berfield, C Stehman-Breen, et al.
Current Medical Research and Opinion|February 13, 2009
Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agentsM R Silver, R Geronemus, M Krause, et al.
Transplantation|January 12, 1999
Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplantsC L Davis, B L Wood, D E Sabath, et al.
Journal of Internal Medicine|November 23, 2006
An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysisA K Agarwal, M R Silver, J E Reed, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2000
Anthropometric measures and risk of death in children with end-stage renal diseaseC S Wong, D S Gipson, D L Gillen, et al.
Kidney International|July 8, 2000
Increased risk of hip fracture among patients with end-stage renal diseaseA M Alem, D J Sherrard, D L Gillen, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Virological Methods|August 23, 2001
Investigating hepatitis C virus heterogeneity in a high prevalence setting using heteroduplex tracking analysisD G Sullivan, S S Kim, J J Wilson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 23, 1999
Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsiesC K Abrass, A K Berfield, C Stehman-Breen, et al.
Current Medical Research and Opinion|February 13, 2009
Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agentsM R Silver, R Geronemus, M Krause, et al.
Transplantation|January 12, 1999
Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplantsC L Davis, B L Wood, D E Sabath, et al.
Journal of Internal Medicine|November 23, 2006
An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysisA K Agarwal, M R Silver, J E Reed, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2000
Anthropometric measures and risk of death in children with end-stage renal diseaseC S Wong, D S Gipson, D L Gillen, et al.
Kidney International|July 8, 2000
Increased risk of hip fracture among patients with end-stage renal diseaseA M Alem, D J Sherrard, D L Gillen, et al.
Pageof 2